Exane Derivatives’s Xilinx Inc XLNX Stock Holding History

Exane Derivatives’s Portfolio XLNX Stock Details XLNX Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q4	–	Sell	-1,612	Closed	-$243K	–	1116
2021 Q3	$243K	Buy	1,612 +127	+9%	+$18.6K	0.06%	342
2021 Q2	$199K	Buy	1,485 +1,470	+9,800%	+$187K	0.05%	389
2021 Q1	$1.86K	Hold	15	–	–	﹤0.01%	684
2020 Q4	$2.13K	Sell	15 -2	-12%	-$260	﹤0.01%	619
2020 Q3	$1.77K	Sell	17 -1,059	-98%	-$109K	﹤0.01%	573
2020 Q2	$106K	Sell	1,076 -120	-10%	-$10.6K	0.03%	284
2020 Q1	$93.2K	Hold	1,196	–	–	0.03%	288
2019 Q4	$118K	Sell	1,196 -103	-8%	-$9.68K	0.02%	300
2019 Q3	$125K	Hold	1,299	–	–	0.02%	298
2019 Q2	$153K	Sell	1,299 -129	-9%	-$15K	0.03%	292
2019 Q1	$181K	Sell	1,428 -27,924	-95%	-$3.14M	0.04%	227
2018 Q4	$2.5M	Sell	29,352 -5,445	-16%	-$455K	0.45%	66
2018 Q3	$2.79M	Buy	34,797 +2,278	+7%	+$167K	0.52%	58
2018 Q2	$2.12M	Buy	32,519 +7,344	+29%	+$501K	0.35%	70
2018 Q1	$1.8M	Buy	25,175 +5,160	+26%	+$372K	0.36%	77
2017 Q4	$1.35M	Buy	+20,015	New	+$1.42M	0.23%	77
2017 Q1	–	Sell	-353	Closed	-$21.3K	–	699
2016 Q4	$21.3K	Hold	353	–	–	﹤0.01%	360
2016 Q3	$19.2K	Hold	353	–	–	﹤0.01%	366
2016 Q2	$16.3K	Sell	353 -720	-67%	-$32.9K	﹤0.01%	345
2016 Q1	$50.9K	Sell	1,073 -956	-47%	-$44.9K	0.01%	308
2015 Q4	$95.3K	Buy	+2,029	New	+$95.9K	0.01%	213

Other funds holding XLNX

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

PCM

Pentwater Capital Management Naples, Florida $16.4B AUM 55.44% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

UBS AM Chicago, Illinois $550B AUM 43.33% 1-Year Est. Return

D.E. Shaw & Co New York $210B AUM 57.28% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Exane Derivatives's XLNX Position: Q4 2021 in Review

Exane Derivatives sold out of Xilinx Inc (XLNX) in Q4 2021, closing a stake of 1,612 shares — an estimated $243K sold.

Exane Derivatives first reported a position in XLNX in Q4 2015 and held it in 21 quarters. The position peaked at $2.79M in Q3 2018. 944 funds tracked by Wall St. Rank hold XLNX as of Q4 2021.

Exane Derivatives reported no remaining Xilinx Inc position as of Q4 2021 after selling out during the quarter.
Exane Derivatives sold 1,612 Xilinx Inc shares in Q4 2021, an estimated $243K.
Exane Derivatives first reported a position in Xilinx Inc in Q4 2015 and held it in 21 quarters.
Exane Derivatives's Xilinx Inc position peaked at $2.79M in Q3 2018.
944 funds tracked by Wall St. Rank held Xilinx Inc as of Q4 2021.

Based on Exane Derivatives's 13F filing for Q4 2021, filed 28 Jan 2022.